Immediate Impact
1 from Science/Nature 52 standout
Citing Papers
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
2024 Standout
Works of Kazutoshi Isobe being referenced
Primary Antiphospholipid Syndrome Associated with Diffuse Alveolar Hemorrhage and Pulmonary Thromboembolism
2015
Effectiveness of combined therapy with pirfenidone and inhaledN ‐acetylcysteine for advanced idiopathic pulmonary fibrosis: A case–control study
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Kazutoshi Isobe | 674 | 286 | 93 | 140 | 104 | 885 | |
| Mitsuhiro Isaka | 603 | 231 | 252 | 109 | 125 | 975 | |
| Kenichi Okubo | 610 | 275 | 231 | 192 | 117 | 1.1k | |
| Yoshihiko Taniguchi | 593 | 682 | 126 | 144 | 100 | 1.2k | |
| Katsunori Kagohashi | 603 | 470 | 131 | 159 | 100 | 985 | |
| Yujiro Takai | 593 | 184 | 75 | 114 | 57 | 851 | |
| F. Vaylet | 593 | 449 | 80 | 132 | 92 | 814 | |
| Tetsuhiko Taira | 627 | 580 | 83 | 185 | 58 | 1.0k | |
| Yasuto Yoneshima | 451 | 638 | 59 | 164 | 54 | 881 | |
| Kazuyuki Tsujino | 448 | 212 | 95 | 188 | 57 | 913 | |
| Koji Takami | 651 | 340 | 258 | 132 | 71 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...